Document Detail


Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor.
MedLine Citation:
PMID:  1173034     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of 5-(4'-chlorobutyl)-picolinic acid (FD-008), a new dopamine beta-hydroxylase inhibitor of fusaric acid derivatives, on the central nervous system in mice and rats were investigated. FD-008 and fusaric acid did not show marked effects on spontaneous movement, convulsion, sleeping time, tremor and conditioned avoidance response but lowered the body temperature of rats at 100 mg/kg p.o. FD-008 potentiated the depressive action of ethanol on conditioned avoidance response in spite of the lack of aldehyde dehydrogenase inhibition. FD-008 markedly depressed the performance on a shuttle box and lowered the body temperature in rats after reserpine treatment at a dose at which FD-008 per se had no effect.
Authors:
Y Ishii; K Natsugoe; H Umezawa
Related Documents :
7389974 - Cryo-ultramicrotomy as a tool for the assessment of doxorubicine cardiotoxicity in rats.
15804494 - The pre-optic anterior hypothalamus (poah) partially mediates the hypothermic response ...
1816564 - Arecoline-associated changes in open-field behavior following swim stress in the rat. a...
10494994 - Acute toxicity of 3,4-methylenedioxymethamphetamine (mdma) in sprague-dawley and dark a...
8834614 - The effect of activated alveolar macrophages on experimental lung emphysema development...
9511184 - Molecular basis of the dark agouti rat drug oxidation polymorphism: importance of cyp2d...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Arzneimittel-Forschung     Volume:  25     ISSN:  0004-4172     ISO Abbreviation:  Arzneimittelforschung     Publication Date:  1975 Feb 
Date Detail:
Created Date:  1975-05-27     Completed Date:  1975-05-27     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0372660     Medline TA:  Arzneimittelforschung     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  213-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aldehyde Oxidoreductases / antagonists & inhibitors
Animals
Avoidance Learning / drug effects
Body Temperature / drug effects
Depression, Chemical
Disulfiram / pharmacology
Dopamine beta-Hydroxylase / antagonists & inhibitors*
Drug Synergism
Electroshock
Ethanol / pharmacology
Hexobarbital / pharmacology
Hydrocarbons, Chlorinated / pharmacology
Injections, Subcutaneous
Lethal Dose 50
Male
Mice
Mice, Inbred ICR
Motor Activity / drug effects
Picolinic Acids / pharmacology*
Rats
Reserpine / pharmacology
Seizures / prevention & control
Sleep / drug effects
Chemical
Reg. No./Substance:
0/Hydrocarbons, Chlorinated; 0/Picolinic Acids; 50-55-5/Reserpine; 56-29-1/Hexobarbital; 64-17-5/Ethanol; 97-77-8/Disulfiram; EC 1.14.17.1/Dopamine beta-Hydroxylase; EC 1.2.-/Aldehyde Oxidoreductases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyp...
Next Document:  Effect of the antrum and vagus nerve on the stimulation of the rat stomach by betazol in the perfusi...